Humanigen, Inc. HGEN
0.00 USD 0.00 (+0.00%)
Jan 4, 2024, 1:45 PM EST
0.0001 Day range 0.0005
0.0001 52-week range 0.239
News
reuters.com US says former Humanigen chief scientific officer charged with insider trading An indictment unsealed on Monday charged the former chief scientific officer of biopharmaceutical company Humanigen with engaging in an insider trading scheme involving the firm's stock, the U.S.…
accesswire.com Levi & Korsinsky, LLP Notifies Shareholders of Humanigen, Inc. (HGEN) an Upcoming Claims Deadline in a Class Action Settlement NEW YORK, NY / ACCESSWIRE / March 5, 2024 / Levi & Korsinsky informs shareholders that a settlement has been reached in the pending class action lawsuit against Humanigen, Inc. (NASDAQ:HGEN). The…
accesswire.com Levi & Korsinsky, LLP Notifies Shareholders of Humanigen, Inc. (HGEN) an Upcoming Claims Deadline in a Class Action Settlement NEW YORK, NY / ACCESSWIRE / February 29, 2024 / Levi & Korsinsky informs shareholders that a settlement has been reached in the pending class action lawsuit against Humanigen, Inc. (NASDAQ:HGEN). The…
investorplace.com HGEN Stock Alert: Why Humanigen Just Filed for Ch. 11 Bankruptcy Humanigen (OTCMKTS: HGEN ) stock is falling hard on Friday after the company filed for Chapter 11 bankruptcy protection. This bankruptcy filing comes after Humanigen failed to secure regulatory…
reuters.com COVID-19 treatment developer Humanigen files for Chapter 11 bankruptcy Drug developer Humanigen HGEN.PK has filed for voluntary Chapter 11 bankruptcy, according to a court filing, after struggling to get regulatory approval for its COVID-19 treatment.
newsfilecorp.com Humanigen Announces First Participant Dosed in RATinG Trial of Lenzilumab for Early Treatment of Acute Graft Versus Host Disease Following Allogeneic Stem Cell Transplantation The RATinG (Risk Adapted Therapy in Acute GvHD) is the first trial to explore granulocyte-macrophage colony-stimulating factor (GM-CSF) neutralization for the early treatment of participants with…
proactiveinvestors.com Humanigen stock removed from S&P Total Market Index as firm faces bankruptcy Humanigen Inc shares have plummeted more than 90% over the past month, and now trades at a little over a penny per share, after the clinical-stage biopharmaceutical company said it is facing…
benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session 
benzinga.com Why Alaska Air Group Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session Gainers Aurora Acquisition Corp. (NASDAQ: AURC) shares jumped 192% to $30.54.
benzinga.com Stocks That Hit 52-Week Lows On Tuesday On Tuesday, 56 companies set new 52-week lows.
benzinga.com Dow Surges 50 Points; General Electric Profit Tops Expectations U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 50 points on Tuesday. The Dow traded up 0.16% to 35,468.65 while the NASDAQ rose 0.60% to 14,142.63. The S&P…- benzinga.com Nasdaq Rises 70 Points; General Motors Posts Upbeat Earnings U.S. stocks traded mixed this morning, with the Nasdaq Composite gaining around 70 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.05% to 35,393.00 while the NASDAQ…
benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session 
investorplace.com Why Is Humanigen (HGEN) Stock Down 72% Today? Humanigen (NASDAQ: HGEN ) stock is falling hard on Tuesday after the company warned investors it can't keep listing requirements. According to a filing from the company, it is no longer compliant…
newsfilecorp.com Humanigen Presents Promising New Hematologic Data from PREACH-M Trial for Chronic Myelomonocytic Leukemia Treatment at the 2023 European Hematology Association Congress Of the 14 participants enrolled and treated with lenzilumab plus azacitidine, ten are evaluable with three to eighteen months of follow-up and all ten have had a rapid clinical response Building upon…
zacks.com Humanigen (HGEN) Surges on Lenzilumab Study Data for Leukemia Humanigen's (HGEN) shares surge after presenting promising early results of its Precision Approach to Chronic Myelomonocytic Leukemia study of lenzilumab in chronic myelomonocytic leukemia.
pennystocks.com 3 Hot Penny Stocks To Watch Today; Is It Time To Buy? Best penny stocks to buy now? 3 to watch in the stock market today.
newsfilecorp.com Humanigen - Lenzilumab Being Studied as a Potential First Treatment in Thirty Years with a Novel Mechanism of Action for Chronic Myelomonocytic Leukemia (CMML), an Orphan Form of Leukemia CMML is an aggressive, poorly understood cancer; approximately 20% of patients survive three years from diagnosis Eleven subjects dosed with lenzilumab and with current standard of care, azacitidine…- benzinga.com Why Sabre Are Trading Lower By 19%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session Gainers Sera Prognostics, Inc. (NASDAQ: SERA) shares surged 63.4% to $2.11 after the company announced top-line data from the AVERT PRETERM TRIAL.
benzinga.com Why Starbox Group Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket Gainers Tricida, Inc. (NASDAQ: TCDA) rose 37.7% to $0.1898 in pre-market trading after gaining 4% on Wednesday.- benzinga.com Stocks That Hit 52-Week Lows On Thursday On Thursday, 116 companies set new 52-week lows.
newsfilecorp.com Humanigen Reports Third Quarter 2022 Financial Results Short Hills, New Jersey--(Newsfile Corp. - November 14, 2022) - Humanigen, Inc. (Nasdaq: HGEN) (Humanigen), a clinical-stage biopharmaceutical company focused on developing lenzilumab (LENZ®), a…
newsfilecorp.com Humanigen Announces Participation and Presentation at Jefferies London Healthcare Conference Short Hills, New Jersey--(Newsfile Corp. - November 10, 2022) - Humanigen, Inc. (Nasdaq: HGEN) ("Humanigen"), a clinical-stage biopharmaceutical company focused on preventing and treating certain…- benzinga.com Why Harsco Shares Surged Over 22%; Here Are 80 Biggest Movers From Yesterday Gainers
newsfilecorp.com Humanigen Announces Retention of SC&H Capital as Financial Advisor Short Hills, New Jersey--(Newsfile Corp. - October 31, 2022) - Humanigen, Inc. (Nasdaq: HGEN) ("Humanigen"), a clinical-stage biopharmaceutical company focused on preventing and treating certain…
prnewswire.com HGEN ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of October 25, 2022 in the Class Action Filed on Behalf of Humanigen, Inc. Shareholders NEW YORK , Oct. 25, 2022 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Humanigen, Inc. (NASDAQ: HGEN) alleging that the…
247wallst.com These Were the Five Best and Worst Performing Healthcare Stocks in Q3 2022 The healthcare industry is now starting to shift its focus away from the coronavirus pandemic to work on its core activities.
newsfilecorp.com HGEN LAWSUIT ALERT: Levi & Korsinsky Notifies Humanigen, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline New York, New York--(Newsfile Corp. - October 24, 2022) - Levi & Korsinsky, LLP notifies investors in Humanigen, Inc. ("Humanigen" or the "Company") (NASDAQ: HGEN) of a class action securities…
prnewswire.com HGEN DEADLINE TOMORROW: ROSEN, SKILLED INVESTOR COUNSEL Encourages Humanigen, Inc. Investors With Losses Exceeding $100K to Secure Counsel Before Important Tuesday Deadline in Securities Class Action - HGEN NEW YORK , Oct. 24, 2022 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Humanigen, Inc. (NASDAQ: HGEN) between May 16, 2020 and July…
prnewswire.com CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Humanigen Investors of a Lead Plaintiff Deadline of October 25, 2022 NEW YORK , Oct. 24, 2022 /PRNewswire/ -- Attention Humanigen, Inc. ("Humanigen") (NASDAQ: HGEN) shareholders: The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on…- benzinga.com Stocks That Hit 52-Week Lows On Friday On Friday morning, 446 companies hit new 52-week lows.
benzinga.com Stocks That Hit 52-Week Lows On Thursday On Thursday, 1076 companies hit new 52-week lows.- benzinga.com Stocks That Hit 52-Week Lows On Wednesday On Wednesday, 340 stocks hit new 52-week lows.
benzinga.com Stocks That Hit 52-Week Lows On Tuesday On Tuesday, 507 stocks hit new 52-week lows.- benzinga.com Stocks That Hit 52-Week Lows On Friday During Friday's session, 574 stocks hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Wednesday On Wednesday, 297 companies achieved new lows for the year.
benzinga.com Stocks That Hit 52-Week Lows On Thursday On Thursday, 529 companies set new 52-week lows.- benzinga.com Stocks That Hit 52-Week Lows On Wednesday On Wednesday, 238 companies achieved new lows for the year.
- benzinga.com Stocks That Hit 52-Week Lows On Tuesday On Tuesday, 250 stocks hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Monday On Monday, 273 companies set new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Friday During Friday's session, 132 stocks hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Monday On Monday, 195 stocks hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Friday On Friday, 109 stocks hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Monday On Monday, 92 companies set new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Thursday On Thursday, 108 companies set new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Monday On Monday, 100 companies reached new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Friday During Friday's session, 61 companies made new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Wednesday On Wednesday, 26 companies achieved new lows for the year.
- benzinga.com Stocks That Hit 52-Week Lows On Friday On Friday, 137 stocks made new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Thursday On Thursday, 550 companies achieved new lows for the year.